ABERRANT HYPEREDITING OF MYELOMA TRANSCRIPTOME BY ADAR1 CONFERS ONCOGENICITY AND IS A MARKER OF POOR PROGNOSIS. (12th June 2019)

Record Type:: Journal Article
Title:: ABERRANT HYPEREDITING OF MYELOMA TRANSCRIPTOME BY ADAR1 CONFERS ONCOGENICITY AND IS A MARKER OF POOR PROGNOSIS. (12th June 2019)
Main Title:: ABERRANT HYPEREDITING OF MYELOMA TRANSCRIPTOME BY ADAR1 CONFERS ONCOGENICITY AND IS A MARKER OF POOR PROGNOSIS
Authors:: Teoh, P.
An, O.
Chung, T.
Chooi, J.
Toh, S.
Fan, S.
Wang, W.
Koh, B.
Fullwood, M.
Ooi, M.
de Mel, S.
Soekojo, C.
Chen, P.
Ng, S.
Yang, H.
Chng, W.
Abstract:
Is Part Of:: Hematological oncology. Volume 37(2019)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 37(2019)Supplement 2
Issue Display:: Volume 37, Issue 2 (2019)
Year:: 2019
Volume:: 37
Issue:: 2
Issue Sort Value:: 2019-0037-0002-0000
Page Start:: 549
Page End:: 549
Publication Date:: 2019-06-12
Subjects:: Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.237_2631 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 12428.xml